{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hôpitaux d'enseignement : Questions médicales les plus fréquentes",
"headline": "Hôpitaux d'enseignement : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hôpitaux d'enseignement : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-09",
"dateModified": "2025-03-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hôpitaux d'enseignement"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hôpitaux",
"url": "https://questionsmedicales.fr/mesh/D006761",
"about": {
"@type": "MedicalCondition",
"name": "Hôpitaux",
"code": {
"@type": "MedicalCode",
"code": "D006761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N02.278.421"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hôpitaux universitaires",
"alternateName": "Hospitals, University",
"url": "https://questionsmedicales.fr/mesh/D006785",
"about": {
"@type": "MedicalCondition",
"name": "Hôpitaux universitaires",
"code": {
"@type": "MedicalCode",
"code": "D006785",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N02.278.421.639.725"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hôpitaux d'enseignement",
"alternateName": "Hospitals, Teaching",
"code": {
"@type": "MedicalCode",
"code": "D006784",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Elizabeth Bernardino",
"url": "https://questionsmedicales.fr/author/Elizabeth%20Bernardino",
"affiliation": {
"@type": "Organization",
"name": "Universidade Federal do Paraná, Curitiba, Paraná, Brazil."
}
},
{
"@type": "Person",
"name": "Niusha Shahidi Sadeghi",
"url": "https://questionsmedicales.fr/author/Niusha%20Shahidi%20Sadeghi",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Mohammadreza Maleki",
"url": "https://questionsmedicales.fr/author/Mohammadreza%20Maleki",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Hassan Abolghasem Gorji",
"url": "https://questionsmedicales.fr/author/Hassan%20Abolghasem%20Gorji",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Soudabeh Vatankhah",
"url": "https://questionsmedicales.fr/author/Soudabeh%20Vatankhah",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Category-specific and category-general neural codes of recognition memory in the ventral visual pathway.",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37207411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cortex.2023.04.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "The features analysis of hemoglobin expression on visual information transmission pathway in early stage of Alzheimer's disease.",
"datePublished": "2024-07-08",
"url": "https://questionsmedicales.fr/article/38972885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-64099-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing.",
"datePublished": "2024-01-26",
"url": "https://questionsmedicales.fr/article/38309185",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2024.103570"
}
},
{
"@type": "ScholarlyArticle",
"name": "Causal effect of COVID-19 on optic nerve and visual pathway disorders: genetic evidence of lung-brain axis.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39081310",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1440262"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retinal structure and visual pathway function at school age in children born extremely preterm: a population-based study.",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/37393251",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-023-03055-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Établissements, main d'oeuvre et services de soins de santé",
"item": "https://questionsmedicales.fr/mesh/D005159"
},
{
"@type": "ListItem",
"position": 3,
"name": "Établissements de santé",
"item": "https://questionsmedicales.fr/mesh/D006268"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hôpitaux",
"item": "https://questionsmedicales.fr/mesh/D006761"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hôpitaux d'enseignement",
"item": "https://questionsmedicales.fr/mesh/D006784"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hôpitaux d'enseignement - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hôpitaux d'enseignement",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hôpitaux d'enseignement",
"description": "Comment les hôpitaux d'enseignement diagnostiquent-ils les maladies ?\nQuel rôle jouent les étudiants en médecine dans le diagnostic ?\nLes hôpitaux d'enseignement utilisent-ils des études de cas ?\nComment les hôpitaux d'enseignement intègrent-ils la recherche dans le diagnostic ?\nQuelles technologies sont utilisées pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006784?mesh_terms=Visual+Pathways&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hôpitaux d'enseignement",
"description": "Comment les hôpitaux d'enseignement identifient-ils les symptômes ?\nLes étudiants peuvent-ils poser des questions sur les symptômes ?\nComment les symptômes sont-ils documentés ?\nLes hôpitaux d'enseignement traitent-ils des symptômes rares ?\nComment les symptômes sont-ils liés aux diagnostics ?",
"url": "https://questionsmedicales.fr/mesh/D006784?mesh_terms=Visual+Pathways&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hôpitaux d'enseignement",
"description": "Quels programmes de prévention sont offerts ?\nComment les étudiants participent-ils à la prévention ?\nLes hôpitaux d'enseignement font-ils de la recherche en prévention ?\nComment la prévention est-elle intégrée dans le cursus ?\nQuels outils sont utilisés pour la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D006784?mesh_terms=Visual+Pathways&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hôpitaux d'enseignement",
"description": "Quels types de traitements sont offerts dans ces hôpitaux ?\nLes étudiants participent-ils aux traitements ?\nComment les traitements sont-ils personnalisés ?\nLes hôpitaux d'enseignement utilisent-ils des traitements expérimentaux ?\nComment les traitements sont-ils évalués ?",
"url": "https://questionsmedicales.fr/mesh/D006784?mesh_terms=Visual+Pathways&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hôpitaux d'enseignement",
"description": "Comment les complications sont-elles gérées ?\nLes étudiants apprennent-ils à gérer les complications ?\nQuelles sont les complications courantes dans ces hôpitaux ?\nComment les complications sont-elles documentées ?\nLes hôpitaux d'enseignement participent-ils à la recherche sur les complications ?",
"url": "https://questionsmedicales.fr/mesh/D006784?mesh_terms=Visual+Pathways&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hôpitaux d'enseignement",
"description": "Comment les facteurs de risque sont-ils identifiés ?\nLes étudiants apprennent-ils sur les facteurs de risque ?\nQuels facteurs de risque sont courants dans ces hôpitaux ?\nComment les hôpitaux d'enseignement abordent-ils les facteurs de risque ?\nLes facteurs de risque sont-ils pris en compte dans les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D006784?mesh_terms=Visual+Pathways&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les hôpitaux d'enseignement diagnostiquent-ils les maladies ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils utilisent des méthodes avancées, des technologies modernes et des équipes multidisciplinaires."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les étudiants en médecine dans le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les étudiants participent sous supervision, apprenant à évaluer les patients et à poser des diagnostics."
}
},
{
"@type": "Question",
"name": "Les hôpitaux d'enseignement utilisent-ils des études de cas ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils analysent des études de cas pour améliorer le diagnostic et la prise en charge des patients."
}
},
{
"@type": "Question",
"name": "Comment les hôpitaux d'enseignement intègrent-ils la recherche dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils appliquent des recherches récentes pour affiner les techniques de diagnostic et les traitements."
}
},
{
"@type": "Question",
"name": "Quelles technologies sont utilisées pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des technologies comme l'IRM, le scanner et les tests génétiques sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Comment les hôpitaux d'enseignement identifient-ils les symptômes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils utilisent des protocoles standardisés et l'expertise des médecins pour évaluer les symptômes."
}
},
{
"@type": "Question",
"name": "Les étudiants peuvent-ils poser des questions sur les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont encouragés à interroger les patients pour mieux comprendre leurs symptômes."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils documentés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont enregistrés dans le dossier médical électronique pour un suivi précis."
}
},
{
"@type": "Question",
"name": "Les hôpitaux d'enseignement traitent-ils des symptômes rares ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent des centres de référence pour des maladies rares et complexes."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils liés aux diagnostics ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aident à orienter le diagnostic et à choisir les examens complémentaires nécessaires."
}
},
{
"@type": "Question",
"name": "Quels programmes de prévention sont offerts ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de vaccination, de dépistage et d'éducation à la santé sont proposés."
}
},
{
"@type": "Question",
"name": "Comment les étudiants participent-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils participent à des campagnes de sensibilisation et à des activités de dépistage."
}
},
{
"@type": "Question",
"name": "Les hôpitaux d'enseignement font-ils de la recherche en prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils mènent des recherches pour développer de nouvelles stratégies de prévention."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle intégrée dans le cursus ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est un élément clé de la formation des étudiants en médecine et des professionnels."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des outils comme des brochures, des ateliers et des applications mobiles sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont offerts dans ces hôpitaux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils offrent des traitements variés, allant de la médecine préventive à la chirurgie complexe."
}
},
{
"@type": "Question",
"name": "Les étudiants participent-ils aux traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sous supervision, ils assistent aux traitements et apprennent des techniques cliniques."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils personnalisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont adaptés en fonction des besoins individuels des patients et de leur état de santé."
}
},
{
"@type": "Question",
"name": "Les hôpitaux d'enseignement utilisent-ils des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils participent souvent à des essais cliniques pour tester de nouveaux traitements."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils évalués ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont évalués par des comités d'éthique et des revues de la littérature médicale."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont gérées par des équipes spécialisées qui évaluent et traitent les cas complexes."
}
},
{
"@type": "Question",
"name": "Les étudiants apprennent-ils à gérer les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont formés à reconnaître et à traiter les complications sous supervision."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes dans ces hôpitaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des réactions aux traitements et des récidives."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles documentées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont enregistrées dans les dossiers médicaux pour améliorer la qualité des soins."
}
},
{
"@type": "Question",
"name": "Les hôpitaux d'enseignement participent-ils à la recherche sur les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils mènent des études pour mieux comprendre et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils identifiés ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont identifiés par des évaluations médicales et des antécédents familiaux des patients."
}
},
{
"@type": "Question",
"name": "Les étudiants apprennent-ils sur les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils étudient les facteurs de risque pour mieux comprendre les maladies et leur prévention."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont courants dans ces hôpitaux ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'obésité, le tabagisme et les antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Comment les hôpitaux d'enseignement abordent-ils les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils mettent en place des programmes de sensibilisation et de prévention ciblant ces facteurs."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils pris en compte dans les traitements ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des facteurs de risque identifiés."
}
}
]
}
]
}
Researchers have identified category-specific brain regions, such as the fusiform face area (FFA) and parahippocampal place area (PPA) in the ventral visual pathway, which respond preferentially to on...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized primarily by cognitive impairment. The motivation of this paper is to explore the impact of the visual information transmission p...
Impaired motion perception in schizophrenia has been associated with deficits in social-cognitive processes and with reduced activation of visual sensory regions, including the middle temporal area (M...
To investigate the potential causal association between COVID-19 exposure and optic nerve and visual pathway disorders through a two-sample bidirectional Mendelian randomization (MR) analysis, and to ...
This MR analysis utilized publicly accessible summary-level data from genome-wide association studies on COVID-19 (n=158,783) and optic nerve and visual pathway diseases (n=412,181), primarily involvi...
In the forward analysis, the inverse-variance weighted method identified a significant causal effect of COVID-19 on optic nerve and visual pathway disorders (odds ratio = 1.697, 95% confidence interva...
Our findings suggest that COVID-19 exposure may increase the risk of developing optic nerve and visual pathway disorders, supporting the lung-brain axis hypothesis. These results underscore the import...
Children born extremely preterm (gestational age < 28 weeks) show reduced visual function even without any cerebral or ophthalmological neonatal diagnosis. In this study, we aimed to assess the retina...
All children born extremely preterm from 2006-2011 (n = 65) in Central Norway were invited to participate. Thirty-six children (55%) with a median age of 13 years (range = 10-16) were examined with OC...
Participants displayed abnormal retinal structure and P100 latencies (≥ 2 SD) compared to reference populations. Moreover, there was a negative correlation between P100 latency in large checks and RNF...
Children born extremely preterm without preterm brain injury sequelae have signs of persistent immaturity of retinal vasculature and neuroretinal layers. Thinner neuroretinal layers are associated wit...
Fixel-based analysis (FBA) is a new method that overcomes the technical limitations of diffusion tensor imaging (DTI) by enabling the characterization of multiple fiber populations within a voxel, and...
In this prospective cross-sectional study, brain DTI scans which were collected with more than six uniformly distributed gradient directions and higher b‑values (up to 2000 s/mm...
Pearson's correlation analysis showed that DTI parameters of white matter (optic nerve, optic chiasma, optic tract, and optic radiation) in the optic pathway were correlated with age. FA values were n...
FBA provides a useful method to assess age-related changes in the visual pathway, which is sensitive to diffusion. In addition, the b‑value influences DTI parameters and signal-to-noise ratio of the i...
Anti-NMDA receptor (NMDAR) encephalitis patients have been reported to exhibit visual dysfunction without retinal thinning. The objective of our study was to examine the involvement of the visual path...
In this cross-sectional study, patients diagnosed with anti-NMDAR encephalitis per consensus criteria underwent postrecovery visual acuity (VA) testing and optical coherence tomography (OCT) with auto...
A total of 16 anti-NMDAR (32 eyes) and 32 HC (64 eyes) were included in the study. Anti-NMDAR exhibited lower low-contrast VA (2.5% contrast: -4.4 letters [95% CI; -8.5 to -0.3]; P = 0.04, 1.25% contr...
Although the visual system seems to be involved in anti-NMDAR encephalitis, no retinal structural or occipital cortex functional abnormalities seem to be responsible for the visual dysfunction. When d...
Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant neurodegenerative disorder characterized by progressive cerebellar ataxia associated with retinal degeneration. The disease is rare in Jap...
The size of the anterior visual pathway (AVP) structures is affected by patient age and pathology. Normative data is useful when determining whether pathology is present. AVP structures do not respect...
For each patient 32 measurements of AVP structures were obtained in 145 children (2 months - 18 years) with normal brain MR studies on high-resolution 3D T2w FSE images adjusted to the axis of each AV...
Descriptive statistics were compiled in a reference table and prediction plots in relation to age, height, and body surface area (BSA) were obtained from the best overall performing statistical model,...
Detailed charts of reference values for AVP structures as well as prediction plots in relation to age, height and BSA were established using axis-corrected measurements from the MPR of high-resolution...
Recovery of vision after acute optic neuritis (AON) is critical to improving the quality of life of people with demyelinating diseases. The objective of the study was to prospectively assess the chang...
We studied a prospective cohort of 88 consecutive patients with AON with 6-month follow-up using high and low-contrast (2.5%) visual acuity, color vision, retinal thickness from optical coherence tomo...
We found that after 6 months, low-contrast vision and quality of vision remained moderately impaired. The thickness of the ganglion cell layer at baseline was a predictor of low-contrast vision 6 mont...
The assessment of the visual pathway at baseline predicts permanent vision disability after AON, indicating that damage is produced early after disease onset and that it can be used for defining visio...